Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 197
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Lymphology ; 50(3): 131-135, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-30234249

RESUMEN

A collateral pathway established after lymphadenectomy could play an important role in long-term lymphedema treatment. The present study investigated alterations of lymph dynamics 1 year after lymphadenectomy using indocyanine green fluorescent lymphography to determine if a collateral pathway may be used for long-term lymphedema treatment. Wistar rats were anaesthetized and lymph nodes were excised at the inguinal and popliteal fossae. The treated hind limb was evaluated by fluorescent lymphography between 10 weeks and 6 months and between 6 months and 1 year postoperatively. Fluorescent lymphography demonstrated a lymphatic pathway to the ipsilateral axillary fossa in all rats 1 year after lymphadenectomy. Some capillary branches in the paths leading to the ipsilateral axillary fossa were dilated and tortuous. In addition, areas in which a fluorescent signal was not visible were increased in the thigh. In conclusion, the collateral pathway did not appear to be only for temporary use to compensate for drainage from the edematous limb but appears more stable as a component of a compensating lymphatic system. These new dilated vessels, although functional at this point, may still be susceptible to disturbance by further alteration to the lymph vessels.

2.
Neuropathol Appl Neurobiol ; 42(3): 279-90, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26111727

RESUMEN

AIMS: Primary central nervous system lymphoma (PCNSL) manifest aggressive clinical behaviour and have poor prognosis. Although constitutive activation of the nuclear factor-κB (NF-κB) pathway has been documented, knowledge about the genetic alterations leading to the impairment of the NF-κB pathway in PCNSLs is still limited. This study was aimed to unravel the underlying genetic profiles of PCNSL. METHODS: We conducted the systematic sequencing of 21 genes relevant to the NF-κB signalling network for 71 PCNSLs as well as the pyrosequencing of CD79B and MYD88 mutation hotspots in a further 35 PCNSLs and 46 glioblastomas (GBMs) for validation. RESULTS: The results showed that 68 out of 71 PCNSLs had mutations in the NF-κB gene network, most commonly affecting CD79B (83%), MYD88 (76%), TBL1XR1 (23%), PRDM1 (20%) and CREBBP1 (20%). These mutations, particularly CD79B and MYD88, frequently coincided within each tumour in various combinations, simultaneously affecting diverse pathways within the network. No GBMs had hotspot mutation of CD79B Y196 and MYD88 L265. CONCLUSIONS: The prevalence of CD79B and MYD88 mutations in PCNSLs was considerably higher than reported in systemic diffuse large B-cell lymphomas. This observation could reflect the paucity of antigen stimuli from the immune system in the central nervous system (CNS) and the necessity to substitute them by the constitutive activation of CD79B and MYD88 that would initiate the signalling cascades. These hotspot mutations may serve as a genetic hallmark for PCNSL serving as a genetic marker for diagnose and potential targets for molecular therapy.


Asunto(s)
Antígenos CD79/genética , Neoplasias del Sistema Nervioso Central/genética , Linfoma de Células B Grandes Difuso/genética , Factor 88 de Diferenciación Mieloide/genética , Anciano , Análisis Mutacional de ADN , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mutación , Reacción en Cadena de la Polimerasa
3.
AJNR Am J Neuroradiol ; 37(1): 44-50, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26381556

RESUMEN

BACKGROUND AND PURPOSE: Noninvasive radiologic evaluation of glioma can facilitate correct diagnosis and detection of malignant transformation. Although positron-emission tomography is considered valuable in the care of patients with gliomas, (18)F-fluorodeoxyglucose and (11)C-methionine have reportedly shown ambiguous results in terms of grading and prognostication. The present study compared the diagnostic and prognostic capabilities of diffusion tensor imaging, FDG, and (11)C-methionine PET in nonenhancing gliomas. MATERIALS AND METHODS: Thirty-five consecutive newly diagnosed, histologically confirmed nonenhancing gliomas that underwent both FDG and (11)C-methionine PET were retrospectively investigated (23 grade II and 12 grade III gliomas). Apparent diffusion coefficient, fractional anisotropy, and tumor-to-normal tissue ratios of both FDG and (11)C-methionine PET were compared between grade II and III gliomas. Prognostic values of these parameters were also tested by using progression-free survival. RESULTS: Grade III gliomas showed significantly higher average tumor-to-normal tissue and maximum tumor2-to-normal tissue than grade II gliomas in (11)C-methionine (P = .013, P = .0017, respectively), but not in FDG-PET imaging. There was no significant difference in average ADC, minimum ADC, average fractional anisotropy, and maximum fractional anisotropy. (11)C-methionine PET maximum tumor-to-normal tissue ratio of 2.0 was most suitable for detecting grade III gliomas among nonenhancing gliomas (sensitivity, 83.3%; specificity, 73.9%). Among patients not receiving any adjuvant therapy, median progression-free survival was 64.2 ± 7.2 months in patients with maximum tumor-to-normal tissue ratio of <2.0 for (11)C-methionine PET and 18.6 ± 6.9 months in patients with maximum tumor-to-normal tissue ratio of >2.0 (P = .0044). CONCLUSIONS: (11)C-methionine PET holds promise for World Health Organization grading and could offer a prognostic imaging biomarker for nonenhancing gliomas.


Asunto(s)
Neoplasias Encefálicas/diagnóstico por imagen , Glioma/diagnóstico por imagen , Clasificación del Tumor/métodos , Tomografía de Emisión de Positrones/métodos , Anciano , Neoplasias Encefálicas/mortalidad , Radioisótopos de Carbono , Supervivencia sin Enfermedad , Femenino , Glioma/mortalidad , Humanos , Masculino , Metionina , Persona de Mediana Edad , Pronóstico , Radiofármacos , Estudios Retrospectivos , Adulto Joven
4.
AJNR Am J Neuroradiol ; 36(5): 904-8, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25593201

RESUMEN

BACKGROUND AND PURPOSE: Although resection of a tumor by trans-sphenoidal surgery is considered the criterion standard for successful surgical treatment of functional pituitary microadenoma, MR imaging occasionally fails to visualize and identify the tumor and supplementary imaging modalities are necessary. We tested the possibility of dynamic contrast-enhanced multisection CT of the pituitary gland accompanying image reconstruction of contrast agent dynamics to identify the localizations of microadenomas and compared the diagnostic performance with conventional pituitary-targeted MR imaging. MATERIALS AND METHODS: Twenty-eight patients with surgically confirmed functional pituitary microadenomas (including growth hormone-, adrenocorticotropic hormone-, and prolactin-secreting adenomas) who underwent pituitary-targeted dynamic contrast-enhanced multisection CT were retrospectively investigated. We undertook image reconstruction of the dynamics of the contrast agent around the pituitary gland in a voxelwise manner, visualizing any abnormality and enabling qualification of contrast dynamics within the tumor. RESULTS: Fifteen cases were correctly diagnosed by MR imaging, while dynamic contrast-enhanced multisection CT correctly diagnosed 26 cases. The accuracy of localization was markedly better for adrenocorticotropic hormone-secreting microadenomas, increasing from 32% on MR imaging to 85% by dynamic contrast-enhanced multisection CT. Compared with the normal pituitary gland, adrenocorticotropic hormone-secreting adenoma showed the least difference in contrast enhancement of the different functional microadenomas. Images acquired at 45-60 seconds after contrast agent injection showed the largest difference in contrast enhancement between an adenoma and the normal pituitary gland. CONCLUSIONS: Dynamic contrast-enhanced multisection CT combined with image reconstruction of the contrast-enhanced dynamics holds promise in detecting MR imaging-occult pituitary microadenomas.


Asunto(s)
Adenoma/diagnóstico , Interpretación de Imagen Asistida por Computador/métodos , Neoplasias Hipofisarias/diagnóstico , Tomografía Computarizada por Rayos X/métodos , Adulto , Anciano , Medios de Contraste , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
5.
Br J Cancer ; 111(12): 2308-15, 2014 Dec 09.
Artículo en Inglés | MEDLINE | ID: mdl-25314067

RESUMEN

BACKGROUND: Nucleostemin (NS) is essential for the maintenance of stem cell properties, the functions of which remain poorly understood in cancer cells. The purpose of this study was to explore the impact of NS on malignancy and its clinical significance in oral squamous cell carcinoma (OSCC) patients. METHODS: We investigated the effects of NS on the proliferation and invasion of OSCC using NS-overexpressing or -knockdown OSCC cells. We assessed the activation of the STAT3 (signal transducer and activator of transcription 3) signalling pathway and the downstream targets in the cells with different expression levels of NS. An immunohistochemical analysis of NS was also performed in 54 OSCC patients who were treated with preoperative chemoradiotherapy and surgery. RESULTS: The overexpression of NS significantly enhanced the proliferation and invasive potential of OSCC cells. On the other hand, downregulation of NS suppressed the invasiveness of the cells. The alterations of these malignant phenotypes were associated with the activation of STAT3 signalling and its downstream targets. An immunohistochemical analysis demonstrated that a high NS tumour expression level significantly correlated with an advanced T-stage and N-stage. Furthermore, a Cox regression analysis revealed that the NS status (hazard ratio, 9.09; P=0.002) was a significant progression factor for OSCC patients. CONCLUSIONS: Our results suggest that targeting NS may provide a promising treatment for highly malignant OSCC.


Asunto(s)
Carcinoma de Células Escamosas/metabolismo , Proteínas de Unión al GTP/biosíntesis , Neoplasias de Cabeza y Cuello/metabolismo , Neoplasias de la Boca/metabolismo , Proteínas Nucleares/biosíntesis , Biomarcadores de Tumor/biosíntesis , Biomarcadores de Tumor/genética , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/patología , Proliferación Celular/fisiología , Proteínas de Unión al GTP/genética , Neoplasias de Cabeza y Cuello/genética , Neoplasias de Cabeza y Cuello/patología , Humanos , Inmunohistoquímica , Neoplasias de la Boca/genética , Proteínas Nucleares/genética , Fenotipo , Pronóstico , Transducción de Señal , Carcinoma de Células Escamosas de Cabeza y Cuello , Transfección
6.
Parasitology ; 139(12): 1652-65, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23036184

RESUMEN

Freshwater fish helminths, the most well known Mexican vertebrate parasites, include approximately 260 species (platyhelminthes, acanthocephalans, nematodes, and hirudineans). The distribution patterns of adult helminth diversity (throughout parasite and host groups and hydrological regions) are described and the effects of host traits and environmental and geographical factors on diversity are evaluated. Adult helminths include 160 species, parasitizing 149 fish species of 23 families distributed in 21 regions. Nematoda was the most species-rich (>50 species). Cichlidae harboured rich helminth assemblages, with widespread parasites. By contrast, Atherinopsidae and Goodeidae showed relatively poor helminth assemblages, including specific parasites with narrow distribution. Helminth richness in southeastern Mexico was higher than northern or central regions. Non-parametric richness estimators were used to avoid confusion in comparisons with unequal sampling efforts. Bootstrap values, the method with the best performance, indicated that estimated richness shows the same distribution pattern that observed richness. Non-phylogenetic and phylogenetic analyses were used to determine the role of different factors in the parasite diversification. The distribution range was the most important richness predictor (widespread fishes harbour richer parasite assemblages), although interactions between this variable and others such as trophic level, latitude, habitat temperature and precipitation are also important. Likewise, biogeographical factors can also affect parasite diversity.


Asunto(s)
Biodiversidad , Enfermedades de los Peces/parasitología , Agua Dulce , Helmintiasis Animal/parasitología , Helmintos/fisiología , Interacciones Huésped-Parásitos , Animales , Peces , Geografía , Helmintos/clasificación , México
7.
Eur J Vasc Endovasc Surg ; 33(5): 625-30, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17223366

RESUMEN

AIM: The complication of nerve injury after greater saphenous vein stripping for varicosity is subjective, and a method for objective evaluation has never been established. The aim of this study was to evaluate postoperative sensory changes by quantitative assessment of current perception threshold (CPT), and to clarify the relation between CPT and symptoms. PATIENTS AND METHODS: Between January 2003 and August 2005, 27 limbs in 18 patients were enrolled. Quantitative sensory function was determined through CPT using a Neurometer (Neurotron, Inc., USA), with which saphenous nerve neural fiber selective minimum sensing values against three electrical stimuli (2000, 250, 5 Hz) were measured. CPT measurements were scheduled on the day before the operation, and 2-7 days, 1, 3, and 6 months after the operation. RESULTS: An increase in CPT value of more than 20% or decrease to below 50% compared to the preoperative value with at least two stimuli was defined as CPT abnormality. Subjective symptoms were observed in 13 limbs in the early postoperative period, and 10 limbs showed CPT abnormality. In 6 limbs with a CPT increase over 20% with all three stimuli, neurological symptoms continued for 6 months. CONCLUSIONS: CPT evaluation provides an objective indication of neurological symptoms in the lower limb following varicose vein surgery.


Asunto(s)
Traumatismos de los Nervios Periféricos , Vena Safena , Anciano , Femenino , Humanos , Pierna/inervación , Masculino , Persona de Mediana Edad , Sensación , Umbral Sensorial
8.
Genes Immun ; 3(8): 477-81, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12486606

RESUMEN

Herpes zoster is a common disease caused by reactivation of the varicella zoster virus (VZV). In a small number of herpes zoster patients, pain persists beyond 4 weeks or more after healing of vesicular eruptions; this condition is termed postherpetic neuralgia (PHN). Positive associations of human histocompatibility leukocyte antigens (HLA) class I antigens, A33 and B44, with PHN in the Japanese population have been reported. Our hypothesis is that susceptibility genes to PHN might exist in the HLA region and the study objective is to further examine possible associations of genes in HLA class I, II and III regions, HLA-A, -B, -DRB1, tumor necrosis factor alpha (TNFA) promoter, and a natural killer cell activating receptor, NKp30 polymorphisms with PHN. Although TNFA or NKp30 in the class III region had been considered as a candidate locus, we found no associations of TNFA promoter or NKp30 polymorphisms with PHN in this study. We demonstrated that HLA-A*3303, -B*4403 and -DRB1*1302 alleles were significantly associated with PHN (P = 0.0007 for A*3303, P = 0.001 for B*4403 and P = 0.001 for DRB1*1302). The frequency of the HLA-A*3303-B*4403-DRB1*1302 haplotype was also significantly higher in the PHN patients than in the healthy controls (P = 0.0039). Our results suggest that this haplotype might be related to the pathogenesis of PHN.


Asunto(s)
Antígenos HLA-A/genética , Antígenos HLA-B/genética , Antígenos HLA-DR/genética , Herpes Zóster/genética , Neuralgia/genética , Neuralgia/inmunología , Receptores Inmunológicos/genética , Factor de Necrosis Tumoral alfa/genética , Adulto , Anciano , Femenino , Ligamiento Genético/genética , Antígeno HLA-B44 , Cadenas HLA-DRB1 , Haplotipos/genética , Humanos , Japón , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/metabolismo , Masculino , Receptor 3 Gatillante de la Citotoxidad Natural , Neuralgia/virología , Polimorfismo Genético/inmunología , Regiones Promotoras Genéticas
9.
FEBS Lett ; 509(2): 250-4, 2001 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-11741598

RESUMEN

Given the potent hydrolyzing activity toward phosphatidylcholine, group X secretory phospholipase A(2) (sPLA(2)-X) elicits a marked release of arachidonic acid linked to the potent production of lipid mediators in various cell types. We have recently shown that sPLA(2)-X can also act as a ligand for mouse phospholipase A(2) receptor (PLA(2)R). Here, we found that sPLA(2)-X was internalized and degraded via binding to PLA(2)R associated with the diminished prostaglandin E(2) (PGE(2)) formation in PLA(2)R-expressing Chinese hamster ovary (CHO) cells compared to CHO cells. Indirect immunocytochemical analysis revealed that internalized sPLA(2)-X was co-localized with PLA(2)R in the punctate structures in PLA(2)R-expressing CHO cells. Moreover, in mouse osteoblastic MC3T3-E(1) cells that endogenously express the PLA(2)R, the internalized sPLA(2)-X was localized in lysosomes. These findings demonstrate that PLA(2)R acts as a clearance receptor for sPLA(2)-X to suppress its strong enzymatic activity.


Asunto(s)
Fosfolipasas A/metabolismo , Receptores de Superficie Celular/metabolismo , Células 3T3 , Animales , Transporte Biológico , Células CHO , Cricetinae , Dinoprostona/biosíntesis , Fosfolipasas A2 Grupo X , Lisosomas/metabolismo , Tasa de Depuración Metabólica , Ratones , Receptores de Fosfolipasa A2
10.
Masui ; 50(9): 1016-8, 2001 Sep.
Artículo en Japonés | MEDLINE | ID: mdl-11593713

RESUMEN

An 86-year-old man complicated by severe asthma developed myocardial infarction after the operation of abdominal aortic aneurysm. Emergency coronary angiography (CAG) revealed 99% stenosis of main trunks of left coronary artery (LMT). Because the patient had been without major coronary risk factors, it was difficult to predict coronary lesions preoperatively. Elderly patients have frequently latent complications not detected by usual consultation. Therefore, in elderly patients, we have to evaluate each individual risk factor more rigidly, and perform more thorough preoperative tests, including CAG.


Asunto(s)
Aneurisma de la Aorta Abdominal/cirugía , Infarto del Miocardio/etiología , Complicaciones Posoperatorias/etiología , Anciano , Anciano de 80 o más Años , Asma/complicaciones , Angiografía Coronaria , Humanos , Masculino , Complicaciones Posoperatorias/diagnóstico , Factores de Riesgo
11.
J Pharmacol Exp Ther ; 298(2): 411-9, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11454901

RESUMEN

Prostaglandin (PG) D2, the major cyclooxygenase metabolite generated from immunologically stimulated mast cells, is thought to contribute to the pathogenesis of allergic diseases due to its various inflammatory effects. However, since no DP receptor antagonist has been developed as an antiallergic drug, the role of PGD2 in the pathogenesis of allergic diseases remains uncertain. Here, we report the in vivo efficacy of our newly established DP receptor antagonist, S-5751 [((Z)-7-[(1R,2R,3S,5S)-2-(5-hydroxy benzo[b]thiophen-3-ylcarbonylamino)-10-norpinan-3-yl]hept-5- enoic acid)], using various allergic inflammation guinea pig models. In allergic rhinitis models, oral administration of S-5751 dramatically inhibited not only early nasal responses, as assessed by sneezing, mucosal plasma exudation, and nasal blockage, but also late responses such as mucosal plasma exudation and eosinophil infiltration. Even when S-5751 was administered after recovery from the early responses, these late phase responses were almost completely suppressed. In addition, S-5751 alleviated allergen-induced plasma exudation in the conjunctiva in an allergic conjunctivitis model and antigen-induced eosinophil infiltration into the lung in an asthma model. These findings provide evidence for the crucial role of PGD2 as a mediator of allergic inflammation in guinea pigs and suggest that DP receptor antagonists may be useful in the treatment of allergic diseases triggered by mast cell activation.


Asunto(s)
Hipersensibilidad/prevención & control , Inflamación/prevención & control , Antagonistas de Prostaglandina/farmacología , Receptores de Prostaglandina/efectos de los fármacos , Tiofenos/farmacología , Animales , Plaquetas/efectos de los fármacos , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Conjuntivitis/tratamiento farmacológico , Conjuntivitis/patología , AMP Cíclico/sangre , Cobayas , Células HL-60 , Humanos , Hipersensibilidad/complicaciones , Técnicas In Vitro , Inflamación/etiología , Ligandos , Masculino , Enfermedades Respiratorias/tratamiento farmacológico , Enfermedades Respiratorias/patología , Rinitis Alérgica Estacional/tratamiento farmacológico , Rinitis Alérgica Estacional/patología
12.
Biochim Biophys Acta ; 1530(1): 67-76, 2001 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-11341959

RESUMEN

We have previously shown the expression of group X secretory phospholipase A(2) (sPLA(2)-X) in mouse splenic macrophages and its powerful potency for releasing fatty acids from various intact cell membranes. Here, we examined the potency of sPLA(2)-X in the production of lipid mediators in murine peritoneal macrophages. Mouse sPLA(2)-X was found to induce a marked release of fatty acids including arachidonic acid and linoleic acid, which contrasted with little, if any, release by the action of group IB and IIA sPLA(2)s. In resting macrophages, sPLA(2)-X elicited a modest production of prostaglandin E(2) and thromboxane A(2). After the induction of cyclooxygenase-2 (COX-2) by pretreatment with lipopolysaccharide, a dramatic increase in the production of these eicosanoids was observed in sPLA(2)-X-treated macrophages, which was completely blocked by the addition of either the specific sPLA(2) inhibitor indoxam or the COX inhibitor indomethacin. In accordance with its higher hydrolyzing activity toward phosphatidylcholine, mouse sPLA(2)-X induced a potent production of lysophosphatidylcholine. These findings strongly suggest that sPLA(2)-X plays a critical role in the production of various lipid mediators from macrophages. These events might be relevant to the progression of various pathological states, including chronic inflammation and atherosclerosis.


Asunto(s)
Macrófagos Peritoneales/metabolismo , Fosfolipasas A/farmacología , Animales , Carbamatos/farmacología , Células Cultivadas , Dinoprostona/metabolismo , Eicosanoides/metabolismo , Inhibidores Enzimáticos/farmacología , Ácidos Grasos/metabolismo , Indolizinas/farmacología , Isoenzimas/metabolismo , Metabolismo de los Lípidos , Lipopolisacáridos , Lisofosfatidilcolinas/metabolismo , Activación de Macrófagos , Ratones , Fosfolipasas A/antagonistas & inhibidores
13.
Masui ; 50(2): 160-3, 2001 Feb.
Artículo en Japonés | MEDLINE | ID: mdl-11244770

RESUMEN

The combination of clonidine hydrochloride, alpha 2-agonist, and opioid is useful for relieving the pain due to surgical procedures or cancer. The routes of administrations used are intravenous, intramuscular as well as intrathecal, epidural and transmucosal. However, transdermal clonidine has not been reported. We, therefore, investigated the analgesic effect of local administration of clonidine ointment. Ten patients with postherpetic neuralgia (PHN) were selected randomly. They were requested to fill out a questionnaire after applying clonidine ointment (150 micrograms/ointment 1 g) to the painful area. Items included in the questionnaire were: effectiveness, visual analog scale (VAS) before and after the administration of clonidine ointment, onset time, with or without allodynia and effectiveness to allodynia in the former case, side effects, and patients' background. Analysis of the answers indicates that clonidine ointment produced a satisfactory effect in nine patients. Onset time was within a few minutes in most patients. No patients suffered any side effects. Specific mechanism of effectiveness or the site affected has not been confirmed in this study, but considering the quick onset, it is presumed that the site where the ointment was applied was the very site that was affected. Clonidine hydrochloride ointment was effective in relieving the symptoms of PHN.


Asunto(s)
Clonidina/administración & dosificación , Herpes Zóster/complicaciones , Neuralgia/tratamiento farmacológico , Administración Tópica , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neuralgia/etiología , Pomadas , Encuestas y Cuestionarios , Resultado del Tratamiento
14.
Behav Brain Res ; 117(1-2): 119-26, 2000 Dec 20.
Artículo en Inglés | MEDLINE | ID: mdl-11099765

RESUMEN

Yawing was induced by microinjections of L-glutamate, cyanide and a nitric oxide-releasing compound (NOC12) into the paraventricular nucleus of the hypothalamus (PVN) in anesthetized, spontaneously breathing rats. To evaluate physiological aspects of yawning, we monitored intercostal electromyogram (EMG) as an index of inspiratory activity, digastric EMG, blood pressure and electrocorticogram (ECoG). Microinjection of L-glutamate in the medial parvocellular subdivision (mp) elicited a stereotyped yawning response, i.e. an initial depressor response and an arousal shift in ECoG followed by a single large inspiration with mouth opening. The same sequential events were observed during spontaneous yawning, indicating that the mp is responsible for triggering yawning. Microinjection of cyanide into the mp caused the same yawning responses as the ones elicited by microinjection of L-glutamate, suggesting that the mp is sensitive to chemical hypoxia or ischemia within the PVN. Microinjection of NOC12 into the mp elicited a single large inspiration with a variable onset delay, suggesting that diffusible nitric oxide (NO) within the mp may act as a paracrine agent to cause a yawning response. We hypothesize that the mp of the PVN contains an oxygen sensor that causes a yawning response.


Asunto(s)
Ácido Glutámico/metabolismo , Hipoxia/inducido químicamente , Donantes de Óxido Nítrico/metabolismo , Óxido Nítrico/fisiología , Compuestos Nitrosos/metabolismo , Núcleo Hipotalámico Paraventricular/efectos de los fármacos , Cianuro de Sodio/farmacología , Bostezo/fisiología , Animales , Isquemia Encefálica/metabolismo , Masculino , Microinyecciones , Óxido Nítrico/metabolismo , Ratas , Ratas Wistar , Umbral Sensorial , Conducta Estereotipada , Bostezo/efectos de los fármacos
15.
Arch Biochem Biophys ; 381(1): 31-42, 2000 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-11019817

RESUMEN

Group X secretory phospholipase A2 (sPLA2-X) has recently been shown to possess a powerful potency for releasing arachidonic acid from cell membrane phospholipids. Here, we report the purification of mouse pro- and mature forms of sPLA2-X, as well as its expression and biological functions. Purified pro-sPLA2-X was found to possess a propeptide of 11 amino acid residues attached at the NH2-terminals of the mature protein, and showed as little as 8% of the PLA2 activity of the mature form. Limited proteolysis of pro-sPLA2-X with trypsin resulted in the appearance of the mature form with a concomitant increase in PLA2 activity, suggesting a requirement of proteolytic removal of the propeptide for the optimal activity. The expression of sPLA2-X mRNA was detected in various tissues including the lung, thymus, and spleen, and immunohistochemical analysis revealed its expression in splenic macrophages. In the spleen cells, mature sPLA2-X elicited a prompt release of arachidonic acid with significant production of prostaglandin E2 more efficiently than group IB and IIA sPLA2s. In addition, sPLA2-X was identified as a high-affinity ligand for both native and recombinant form of mouse PLA2 receptor (PLA2R). However, there was no significant difference in the sPLA2-X-induced arachidonic acid release responses in the spleen cells between wild-type and PLA2R-deficient mice. These findings strongly suggest that sPLA2-X possesses two distinct biological functions in mice: it elicits a marked release of arachidonic acid from membrane phospholipids leading to the production of lipid mediators based on its enzymatic potency, and it acts as a natural ligand for the PLA2R that has been shown to play a critical role in the production of inflammatory cytokines during endotoxic shock.


Asunto(s)
Ácido Araquidónico/metabolismo , Fosfolipasas A/metabolismo , Receptores de Superficie Celular/metabolismo , Bazo/metabolismo , Animales , Precursores Enzimáticos/genética , Precursores Enzimáticos/metabolismo , Femenino , Fosfolipasas A2 Grupo II , Fosfolipasas A2 Grupo X , Inmunohistoquímica , Técnicas In Vitro , Cinética , Ligandos , Masculino , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Fosfolipasas A/genética , Fosfolipasas A2 , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores de Fosfolipasa A2 , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Distribución Tisular
16.
FEBS Lett ; 478(1-2): 187-91, 2000 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-10922494

RESUMEN

Phospholipase A(2) receptor (PLA(2)R) mediates various biological responses elicited by group IB secretory phospholipase A(2) (sPLA(2)-IB). The recently cloned group X sPLA(2) (sPLA(2)-X) possesses several structural features characteristic of sPLA(2)-IB. Here, we detected a specific binding site of sPLA(2)-X in mouse osteoblastic MC3T3-E(1) cells. Cross-linking experiments demonstrated its molecular weight (180 kDa) to be similar to that of PLA(2)R. In fact, sPLA(2)-X was found to bind the recombinant PLA(2)R expressed in COS-7 cells, and its specific binding detected in mouse lung membranes was abolished by the deficiency of PLA(2)R. These findings demonstrate sPLA(2)-X to be one of the high-affinity ligands for mouse PLA(2)R.


Asunto(s)
Fosfolipasas A/metabolismo , Receptores de Superficie Celular/metabolismo , Animales , Sitios de Unión , Línea Celular , Membrana Celular/metabolismo , Cricetinae , Reactivos de Enlaces Cruzados , Fosfolipasas A2 Grupo II , Ligandos , Pulmón/citología , Ratones , Peso Molecular , Osteoblastos/citología , Osteoblastos/metabolismo , Receptores de Superficie Celular/deficiencia , Receptores de Superficie Celular/genética , Receptores de Fosfolipasa A2 , Proteínas Recombinantes/metabolismo , Porcinos , Termodinámica , Transfección
17.
Arch Biochem Biophys ; 379(1): 7-17, 2000 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-10864436

RESUMEN

Phospholipase A(2) receptor (PLA(2)R) mediates a variety of biological responses elicited by mammalian secretory phospholipase A(2) (sPLA(2)). In mice, group IB sPLA(2) (sPLA(2)-IB) acts as an endogenous ligand of PLA(2)R, and analysis of PLA(2)R-deficient mice has demonstrated a critical role of the sPLA(2)-IB/PLA(2)R system in the production of proinflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) in the development of endotoxic shock. Here, we generated specific antibodies against a recombinant soluble form of PLA(2)R and examined its expression in the lung and spleen where a remarkable elevation of TNF-alpha expression has been observed during endotoxemia. Immunohistochemical analysis revealed the expression of PLA(2)R in type II alveolar epithelial cells and a subset of splenic lymphocytes, and its expression levels were markedly enhanced at 1 h after endotoxin challenge. Analysis with a newly developed sandwich enzyme-linked immunosorbent assay system revealed the presence of a soluble form of PLA(2)R in plasma of wild-type mice compared with its absence in plasma of PLA(2)R-deficient mice. After exposure to endotoxin, its circulating level was significantly elevated to the maximum level at 2-3 h after the treatment. These results suggest that tissue expression and the circulating level of PLA(2)R are elevated during murine endotoxemia, which might be relevant to its potential roles in the production of proinflammatory mediators during the development of inflammatory conditions.


Asunto(s)
Receptores de Superficie Celular/metabolismo , Choque Séptico/metabolismo , Células 3T3 , Animales , Anticuerpos Monoclonales/inmunología , Células CHO , Cricetinae , Ensayo de Inmunoadsorción Enzimática , Fosfolipasas A2 Grupo II , Inmunohistoquímica , Inflamación/inmunología , Lipopolisacáridos/farmacología , Pulmón/metabolismo , Ratones , Fosfolipasas A/metabolismo , Receptores de Superficie Celular/sangre , Receptores de Superficie Celular/inmunología , Receptores de Fosfolipasa A2 , Proteínas Recombinantes/inmunología , Choque Séptico/sangre , Bazo/metabolismo , Factores de Tiempo , Factor de Necrosis Tumoral alfa/inmunología , Factor de Necrosis Tumoral alfa/metabolismo
18.
J Biol Chem ; 275(2): 1279-86, 2000 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-10625674

RESUMEN

A novel eosinophil chemotactic cytokine (ECF-L) was purified from the culture supernatant of splenocytes of mice by a combination of anion-exchange chromatography, Procion red-agarose affinity chromatography, size exclusion high performance liquid chromatography (HPLC), and reverse phase HPLC. The NH(2)-terminal amino acid sequence was determined by direct protein sequencing. An ECF-L cDNA clone of 1,506 nucleotides was isolated from a cDNA library, and the nucleotide sequence predicted a mature protein of 397 amino acids. A recombinant ECF-L showed a level of eosinophil chemotactic activity comparable with that of natural ECF-L, and the activity was inhibited by a monoclonal antibody to ECF-L. ECF-L also attracted T lymphocytes and bone marrow polymorphonuclear leukocytes in vitro, whereas it caused selective extravasation of eosinophils in vivo. ECF-L mRNA was highly expressed in spleen, bone marrow, lung, and heart. A comprehensive GenBank data base search revealed that ECF-L is a chitinase family protein. ECF-L retains those amino acids highly conserved among chitinase family proteins, but Asp and Glu residues essential for the proton donation in hydrolysis were replaced by Asn and Gln, respectively. Although ECF-L contains a consensus CXC sequence near the NH(2) terminus akin to chemokine family proteins, the rest of ECF-L shows poor homology with chemokines.


Asunto(s)
Infecciones por Cestodos/fisiopatología , Factores Quimiotácticos Eosinófilos/fisiología , Quitinasas/fisiología , Eosinófilos/fisiología , Neutrófilos/fisiología , Esquistosomiasis Japónica/fisiopatología , Transcripción Genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Infecciones por Cestodos/sangre , Quimiocinas CC/química , Quimiocinas CXC/química , Factores Quimiotácticos Eosinófilos/química , Factores Quimiotácticos Eosinófilos/genética , Quitinasas/química , Quitinasas/genética , Cromatografía Líquida de Alta Presión , Eosinófilos/parasitología , Femenino , Regulación de la Expresión Génica , Humanos , Linfocitos/química , Linfocitos/inmunología , Macrófagos/parasitología , Macrófagos/fisiología , Mesocestoides , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Datos de Secuencia Molecular , Neutrófilos/parasitología , ARN Mensajero/genética , Schistosoma japonicum , Esquistosomiasis Japónica/sangre , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Bazo/inmunología
19.
FEBS Lett ; 487(2): 262-6, 2000 Dec 29.
Artículo en Inglés | MEDLINE | ID: mdl-11150521

RESUMEN

Although the cyclooxygenase-2 (COX-2) pathway of the arachidonic acid cascade has been suggested to play an important role in colon carcinogenesis, there is little information concerning the identity of phospholipase A(2) (PLA(2)) involved in the arachidonic acid release in colon tumors. Here, we compared the potencies of three types of secretory PLA(2)s (group IB, IIA and X sPLA(2)s) for the arachidonic acid release from cultured human colon adenocarcinoma cells, and found that group X sPLA(2) has the most powerful potency in the release of arachidonic acid leading to COX-2-dependent prostaglandin E(2) (PGE(2)) formation. Furthermore, immunohistological analysis revealed the elevated expression of group X sPLA(2) in human colon adenocarcinoma neoplastic cells in concert with augmented expression of COX-2. These findings suggest a critical role of group X sPLA(2) in the PGE(2) biosynthesis during colon tumorigenesis.


Asunto(s)
Adenocarcinoma/enzimología , Neoplasias del Colon/enzimología , Dinoprostona/metabolismo , Fosfolipasas A/metabolismo , Prostaglandina-Endoperóxido Sintasas/metabolismo , Adenocarcinoma/patología , Adenocarcinoma/fisiopatología , Colon/enzimología , Colon/patología , Neoplasias del Colon/patología , Neoplasias del Colon/fisiopatología , Neoplasias Colorrectales/enzimología , Neoplasias Colorrectales/patología , Ciclooxigenasa 1 , Ciclooxigenasa 2 , Fosfolipasas A2 Grupo II , Humanos , Isoenzimas/genética , Isoenzimas/metabolismo , Proteínas de la Membrana , Prostaglandina-Endoperóxido Sintasas/genética , Proteínas Recombinantes/metabolismo , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA